연속혈당측정시스템(CGMS) 시장 : 구성요소, 인구통계, 환자 유형, 최종 사용자, 유통 채널별 - 세계 예측(2025-2030년)

The Continuous Glucose Monitoring Systems Market was valued at USD 5.54 billion in 2023, expected to reach USD 6.21 billion in 2024, and is projected to grow at a CAGR of 12.37%, to USD 12.55 billion by 2030.

Continuous Glucose Monitoring (CGM) systems are devices used to track glucose levels in the interstitial fluid of diabetes patients continuously. These systems typically consist of a small sensor inserted under the skin, a transmitter that sends data, and a receiver or a compatible smart device for monitoring. The primary necessity for CGM stems from its capability to provide real-time glucose readings, alert users about glucose fluctuations, and ease the management of diabetes. The applications of CGM include monitoring blood glucose levels in Type 1 and Type 2 diabetes patients to avoid hypoglycemic or hyperglycemic events. End-use scopes are wide, encompassing healthcare settings, outpatient settings, and home care for diabetes management and preventive care.

Market growth for CGM systems is significantly driven by the increasing prevalence of diabetes, rising awareness and acceptance of advanced diagnostics, and a growing emphasis on preventive healthcare. Technological innovations such as integration with smart devices and wearables, as well as improvements in sensor accuracy and comfort, present substantial opportunities for market expansion. Companies can capitalize on these opportunities by investing in R&D to enhance device accuracy, reduce costs, and improve user experience. However, market growth faces challenges like high costs, limited insurance reimbursement in certain regions, and regulatory hurdles. Scalability issues and the need for frequent calibration can also limit widespread adoption.

The CGM market presents opportunities for innovation, particularly in developing non-invasive monitoring systems, enhancing data analytics capabilities for personalized health insights, and integrating artificial intelligence to predict glucose trends. Partnerships with tech giants for digital health platforms could also be beneficial. Despite its promising landscape, the market requires navigating technical validation, addressing affordability issues for broader access, and emphasizing education to improve chronic disease management. Overall, continuous advancements in CGM technology and favorable policies towards digital healthcare solutions can propel the market into new dimensions, offering enhanced quality of life for diabetes patients.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Continuous Glucose Monitoring Systems Market

The Continuous Glucose Monitoring Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing Number of Incidence of Diabetic Patients Globally
  • Growing Regulatory Approvals for the CGM Systems
  • Growing Adoption Rate of CGM Systems in Home Healthcare
• Market Restraints
  • Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
• Market Opportunities
  • Technological Advancements and Increased Awareness of CGM Systems
  • Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
• Market Challenges
  • Reimbursement and Stringent Regulatory Issues

Porter's Five Forces: A Strategic Tool for Navigating the Continuous Glucose Monitoring Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Continuous Glucose Monitoring Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Continuous Glucose Monitoring Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Continuous Glucose Monitoring Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Continuous Glucose Monitoring Systems Market

A detailed market share analysis in the Continuous Glucose Monitoring Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Continuous Glucose Monitoring Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Continuous Glucose Monitoring Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Continuous Glucose Monitoring Systems Market, highlighting leading vendors and their innovative profiles. These include NXP Semiconductors N.V., Senseonics Holdings Inc., Nemaura Medical Inc., Sibionics, Insulet Corporation, Abbott Laboratories, AgaMatrix Inc. by I-Sens Inc., Ascensia Diabetes Care Holdings AG, Novo Nordisk A/S, Ypsomed Holding AG, STMicroelectronics N.V., Johnson & Johnson Services, Inc., Tandem Diabetes Care, Inc., F. Hoffmann-La Roche Ltd., A. Menarini Diagnostics s.r.l, Dexcom, Inc., Medtrum Technologies Inc., Texas Instruments Incorporated, and Medtronic PLC.

Market Segmentation & Coverage

This research report categorizes the Continuous Glucose Monitoring Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Component, market is studied across Integrated Insulin Pumps, Sensors, and Transmitters & Receivers.
• Based on Demographics, market is studied across Adult Population and Children Population.
• Based on Patient Type, market is studied across Type 1 Diabetes and Type 2 Diabetes.
• Based on End User, market is studied across Diagnostic Centers & Clinics, Home Healthcare, and ICUs.
• Based on Distribution Channel, market is studied across Institutional Sales and Retail Sales.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing Number of Incidence of Diabetic Patients Globally
    • 5.1.1.2. Growing Regulatory Approvals for the CGM Systems
    • 5.1.1.3. Growing Adoption Rate of CGM Systems in Home Healthcare
  • 5.1.2. Restraints
    • 5.1.2.1. Occurrence of Adverse Effects and Limited Accuracy of CGM Devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological Advancements and Increased Awareness of CGM Systems
    • 5.1.3.2. Rising Preferences for Non-invasive Methods and Potential Undiagnosed Patient Population
  • 5.1.4. Challenges
    • 5.1.4.1. Reimbursement and Stringent Regulatory Issues
• 5.2. Market Segmentation Analysis
  • 5.2.1. Component: Increasing utilization of transmitters & receivers in CGM systems for real-time glucose monitoring
  • 5.2.2. Demographics: Ongoing advancements in children CGM systems to make it more effective and less invasive
  • 5.2.3. Patient Type: Rising significance of CGM system in Type 1 diabetes patient for high accuracy, minimal lag time, and predictive alerts for rapid glucose changes
  • 5.2.4. End User: Growing preference of CGM systems by home patients with remote data sharing capabilities
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental
• 5.5. Client Customization

6. Continuous Glucose Monitoring Systems Market, by Component

• 6.1. Introduction
• 6.2. Integrated Insulin Pumps
• 6.3. Sensors
• 6.4. Transmitters & Receivers

7. Continuous Glucose Monitoring Systems Market, by Demographics

• 7.1. Introduction
• 7.2. Adult Population
• 7.3. Children Population

8. Continuous Glucose Monitoring Systems Market, by Patient Type

• 8.1. Introduction
• 8.2. Type 1 Diabetes
• 8.3. Type 2 Diabetes

9. Continuous Glucose Monitoring Systems Market, by End User

• 9.1. Introduction
• 9.2. Diagnostic Centers & Clinics
• 9.3. Home Healthcare
• 9.4. ICUs

10. Continuous Glucose Monitoring Systems Market, by Distribution Channel

• 10.1. Introduction
• 10.2. Institutional Sales
• 10.3. Retail Sales

11. Americas Continuous Glucose Monitoring Systems Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Continuous Glucose Monitoring Systems Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Continuous Glucose Monitoring Systems Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. Sibionics obtains CE Mark for GS1 continuous glucose monitoring system
  • 14.3.2. Dexcom targets Americans with new CGM aimed at non-insulin-using diabetics
  • 14.3.3. U.S. FDA Clears Abbott's Freestyle Libre 2 and Freestyle Libre 3 Sensors for Integration with Automated Insulin Delivery Systems

Companies Mentioned

• 1. NXP Semiconductors N.V.
• 2. Senseonics Holdings Inc.
• 3. Nemaura Medical Inc.
• 4. Sibionics
• 5. Insulet Corporation
• 6. Abbott Laboratories
• 7. AgaMatrix Inc. by I-Sens Inc.
• 8. Ascensia Diabetes Care Holdings AG
• 9. Novo Nordisk A/S
• 10. Ypsomed Holding AG
• 11. STMicroelectronics N.V.
• 12. Johnson & Johnson Services, Inc.
• 13. Tandem Diabetes Care, Inc.
• 14. F. Hoffmann-La Roche Ltd.
• 15. A. Menarini Diagnostics s.r.l
• 16. Dexcom, Inc.
• 17. Medtrum Technologies Inc.
• 18. Texas Instruments Incorporated
• 19. Medtronic PLC